← Back to Search

Behavioral Intervention

Wellness Intervention for Smoking Cessation in Veterans with HIV (WISH Trial)

N/A

Recruiting

Led By Kristina Crothers, MD

Research Sponsored by Seattle Institute for Biomedical and Clinical Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

HIV+ serostatus

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, 12 months post-randomization

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare an HIV-specific wellness intervention to standard care (referral to national VA Quitline and SmokefreeVET texting program) to see which is more effective.

Who is the study for?

This trial is for veterans living with HIV who smoke at least 5 cigarettes a day, are in VA care, can text, and speak English. It's not for those with hearing/comprehension issues, institutionalized individuals, people with severe cognitive impairments, pregnant women or anyone already getting help to quit smoking.

What is being tested?

The study compares a wellness intervention tailored for smokers with HIV against standard services like the National VA Quitline and SmokefreeVET texting. Participants also have access to quitting medications through their VA healthcare providers.

What are the potential side effects?

Since this trial focuses on behavioral interventions rather than medication, direct side effects from the interventions are minimal. However, participants may experience stress or anxiety related to attempting to quit smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am HIV positive.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, 12 months post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, 12 months post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 12 months post-randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

7-day point-prevalence abstinence (PPA)

Any 24-hour intentional quit attempt

Secondary study objectives

30-day self-report point-prevalence abstinence (PPA)

7-day self-report point-prevalence abstinence (PPA)

Absolute CD4 count

+9 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention - Wellness Intervention for Smokers with HIVExperimental Treatment1 Intervention

The experimental WISH intervention is an HIV-specific comprehensive wellness program designed to offer integrated phone and text counseling regardless of readiness to quit.

Group II: Control - Standard CareActive Control1 Intervention

The control intervention is referral to standard evidence-based cessation services available nationally to Veterans, including the National VA Quitline and SmokefreeVET texting program.

0 / 1Eligibility criteria met